Tempus AI Gross Profit 2023-2025 | TEM

Tempus AI annual/quarterly gross profit history and growth rate from 2023 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Tempus AI gross profit for the quarter ending March 31, 2025 was $0.155B, a 99.75% increase year-over-year.
  • Tempus AI gross profit for the twelve months ending March 31, 2025 was $0.459B, a 50.41% increase year-over-year.
  • Tempus AI annual gross profit for 2024 was $0.381B, a 33.17% increase from 2023.
  • Tempus AI annual gross profit for 2023 was $0.286B, a 119.82% increase from 2022.
  • Tempus AI annual gross profit for 2022 was $0.13B, a 0% decline from .
Tempus AI Annual Gross Profit
(Millions of US $)
2024 $381
2023 $286
2022 $130
Tempus AI Quarterly Gross Profit
(Millions of US $)
2025-03-31 $155
2024-12-31 $122
2024-09-30 $106
2024-06-30 $76
2024-03-31 $78
2023-12-31 $82
2023-09-30 $74
2023-06-30 $72
2023-03-31 $59
2022-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $10.569B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.567B 53.27
Hims & Hers Health (HIMS) United States $11.630B 120.84
Inspire Medical Systems (INSP) United States $4.461B 69.70
IRhythm Technologies (IRTC) United States $4.396B 0.00
Privia Health (PRVA) United States $3.035B 208.50
Enovis (ENOV) United States $1.887B 10.53
Clover Health Investments (CLOV) United States $1.793B 0.00
Schrodinger (SDGR) United States $1.746B 0.00
Phreesia (PHR) United States $1.506B 0.00
Azenta (AZTA) United States $1.223B 56.96
Omnicell (OMCL) United States $1.208B 21.31
10x Genomics (TXG) United States $1.073B 0.00
Fulgent Genetics (FLGT) United States $0.600B 0.00
Butterfly Network (BFLY) United States $0.551B 0.00
Talkspace (TALK) United States $0.509B 151.00
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.406B 0.00
TruBridge (TBRG) United States $0.371B 827.00
Claritev (CTEV) United States $0.351B 0.00
Health Catalyst (HCAT) United States $0.290B 0.00
Nyxoah SA (NYXH) Belgium $0.215B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.195B 0.00
EUDA Health Holdings (EUDA) Singapore $0.144B 0.00
Pulmonx (LUNG) United States $0.136B 0.00
American Well (AMWL) United States $0.107B 0.00
Retrieve Medical Holdings (RMHI) United States $0.089B 0.00
MDxHealth SA (MDXH) Belgium $0.088B 0.00
CareCloud (CCLD) United States $0.081B 3.07
111 (YI) China $0.068B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.060B 0.00
Outset Medical (OM) United States $0.055B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00